Kidneys Home > Rapamune Medication Information

As an immunosuppressant, Rapamune® (sirolimus) is approved to prevent organ rejection in people who have received a kidney transplant. It is used in combination with other medicines and is taken once a day. Rapamune is sold as a tablet and an oral solution (liquid).
In clinical studies, the most commonly reported side effects of this medication included:
It's important to review Rapamune's safety information with your healthcare provider before starting treatment. This medication may not be suitable for everyone, so make sure your healthcare provider is aware if you have any other medical conditions, such as high blood pressure, hepatitis, or skin cancer, or if you are taking any other types of medicine.
(Click Rapamune for more information on this medication, including how to use it, other safety issues to keep in mind during treatment, and how it works.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.